BioCryst Pharmaceuticals, Inc.
לונג

BCRX may start an uptrend

201
After a bit of correction and going down to sub $9 last week, buy side was more powerful Friday afternoon, and the SP climbed above $9.50... $10 is a first level resistance point, but once it is achieved, we can expect the SP to run towards $11.80... Support would be around $8.80 but considering the earnings was moved 2 weeks earlier (which may be a good sign), Factor D news, EU Orladeyo approval and upcoming Q1 earnings, the stock is believed to be in a positive momentum...

My analysis are not investment advice. Always do your own DD and take your own decisions.

כתב ויתור

המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.